These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

449 related items for PubMed ID: 21572151

  • 21. The Canadian methotrexate and etanercept outcome study: a randomised trial of discontinuing versus continuing methotrexate after 6 months of etanercept and methotrexate therapy in rheumatoid arthritis.
    Pope JE, Haraoui B, Thorne JC, Vieira A, Poulin-Costello M, Keystone EC.
    Ann Rheum Dis; 2014 Dec; 73(12):2144-51. PubMed ID: 23979914
    [Abstract] [Full Text] [Related]

  • 22. Etanercept added to background methotrexate therapy in patients with rheumatoid arthritis: continued observations.
    Kremer JM, Weinblatt ME, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Jackson CG, Atkins KM, Feng A, Burge DJ.
    Arthritis Rheum; 2003 Jun; 48(6):1493-9. PubMed ID: 12794815
    [Abstract] [Full Text] [Related]

  • 23. Factors associated with radiographic progression in patients with rheumatoid arthritis who were treated with methotrexate.
    Weinblatt ME, Keystone EC, Cohen MD, Freundlich B, Li J, Chon Y, Baumgartner SW.
    J Rheumatol; 2011 Feb; 38(2):242-6. PubMed ID: 21078715
    [Abstract] [Full Text] [Related]

  • 24. A multicenter, randomized, double-blind clinical trial of combination therapy with Anbainuo, a novel recombinant human TNFRII:Fc fusion protein, plus methotrexate versus methotrexate alone or Anbainuo alone in Chinese patients with moderate to severe rheumatoid arthritis.
    Chen XX, Dai Q, Huang AB, Wu HX, Zhao DB, Li XF, Hu SX, Yang NP, Tao Y, Xu JH, Jiang LD, Bao CD.
    Clin Rheumatol; 2013 Jan; 32(1):99-108. PubMed ID: 23053688
    [Abstract] [Full Text] [Related]

  • 25. Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial.
    Emery P, Breedveld FC, Hall S, Durez P, Chang DJ, Robertson D, Singh A, Pedersen RD, Koenig AS, Freundlich B.
    Lancet; 2008 Aug 02; 372(9636):375-82. PubMed ID: 18635256
    [Abstract] [Full Text] [Related]

  • 26. Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis.
    van der Heijde D, Klareskog L, Landewé R, Bruyn GA, Cantagrel A, Durez P, Herrero-Beaumont G, Molad Y, Codreanu C, Valentini G, Zahora R, Pedersen R, MacPeek D, Wajdula J, Fatenejad S.
    Arthritis Rheum; 2007 Dec 02; 56(12):3928-39. PubMed ID: 18050208
    [Abstract] [Full Text] [Related]

  • 27. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis.
    Bathon JM, Martin RW, Fleischmann RM, Tesser JR, Schiff MH, Keystone EC, Genovese MC, Wasko MC, Moreland LW, Weaver AL, Markenson J, Finck BK.
    N Engl J Med; 2000 Nov 30; 343(22):1586-93. PubMed ID: 11096165
    [Abstract] [Full Text] [Related]

  • 28. Safety and efficacy of etanercept treatment in elderly subjects with rheumatoid arthritis.
    Bathon JM, Fleischmann RM, Van der Heijde D, Tesser JR, Peloso PM, Chon Y, White B.
    J Rheumatol; 2006 Feb 30; 33(2):234-43. PubMed ID: 16465653
    [Abstract] [Full Text] [Related]

  • 29. Etanercept for the treatment of rheumatoid arthritis.
    Blumenauer B, Judd M, Cranney A, Burls A, Coyle D, Hochberg M, Tugwell P, Wells G.
    Cochrane Database Syst Rev; 2003 Feb 30; (4):CD004525. PubMed ID: 14584021
    [Abstract] [Full Text] [Related]

  • 30. Longterm safety, efficacy, and radiographic outcome with etanercept treatment in patients with early rheumatoid arthritis.
    Genovese MC, Bathon JM, Fleischmann RM, Moreland LW, Martin RW, Whitmore JB, Tsuji WH, Leff JA.
    J Rheumatol; 2005 Jul 30; 32(7):1232-42. PubMed ID: 15996057
    [Abstract] [Full Text] [Related]

  • 31. Phase III, multicentre, double-blind, randomised, parallel-group study to evaluate the similarities between LBEC0101 and etanercept reference product in terms of efficacy and safety in patients with active rheumatoid arthritis inadequately responding to methotrexate.
    Matsuno H, Tomomitsu M, Hagino A, Shin S, Lee J, Song YW.
    Ann Rheum Dis; 2018 Apr 30; 77(4):488-494. PubMed ID: 29259050
    [Abstract] [Full Text] [Related]

  • 32. Correlation of radiographic progression with the cumulative activity of synovitis estimated by power Doppler ultrasound in rheumatoid arthritis: difference between patients treated with methotrexate and those treated with biological agents.
    Ikeda K, Nakagomi D, Sanayama Y, Yamagata M, Okubo A, Iwamoto T, Kawashima H, Takahashi K, Nakajima H.
    J Rheumatol; 2013 Dec 30; 40(12):1967-76. PubMed ID: 24187096
    [Abstract] [Full Text] [Related]

  • 33. Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis.
    Culy CR, Keating GM.
    Drugs; 2002 Dec 30; 62(17):2493-537. PubMed ID: 12421111
    [Abstract] [Full Text] [Related]

  • 34. Improvements in clinical response between 12 and 24 weeks in patients with rheumatoid arthritis on etanercept therapy with or without methotrexate.
    Kavanaugh A, Klareskog L, van der Heijde D, Li J, Freundlich B, Hooper M.
    Ann Rheum Dis; 2008 Oct 30; 67(10):1444-7. PubMed ID: 18535115
    [Abstract] [Full Text] [Related]

  • 35. Patients with moderate rheumatoid arthritis (RA) achieve better disease activity states with etanercept treatment than patients with severe RA.
    Keystone E, Freundlich B, Schiff M, Li J, Hooper M.
    J Rheumatol; 2009 Mar 30; 36(3):522-31. PubMed ID: 19228659
    [Abstract] [Full Text] [Related]

  • 36. Safety and effectiveness of 6 months' etanercept monotherapy and combination therapy in Japanese patients with rheumatoid arthritis: effect of concomitant disease-modifying antirheumatic drugs.
    Koike T, Harigai M, Inokuma S, Ishiguro N, Ryu J, Takeuchi T, Tanaka Y, Yamanaka H, Hirose T, Yoshinaga T, Suzukawa M.
    J Rheumatol; 2013 Oct 30; 40(10):1658-68. PubMed ID: 23908446
    [Abstract] [Full Text] [Related]

  • 37. Inhibition of radiographic progression with combination etanercept and methotrexate in patients with moderately active rheumatoid arthritis previously treated with monotherapy.
    van der Heijde D, Burmester G, Melo-Gomes J, Codreanu C, Martin Mola E, Pedersen R, Robertson D, Chang D, Koenig A, Freundlich B, Etanercept Study Investigators.
    Ann Rheum Dis; 2009 Jul 30; 68(7):1113-8. PubMed ID: 18718986
    [Abstract] [Full Text] [Related]

  • 38. Etanercept in combination with conventional disease-modifying antirheumatic drugs (DMARDs) in the treatment of rheumatoid arthritis patients intolerant to methotrexate.
    Koyama Y, Shiraishi H, Ohta T, Uchino A.
    Mod Rheumatol; 2012 Feb 30; 22(1):100-8. PubMed ID: 21706263
    [Abstract] [Full Text] [Related]

  • 39. Efficacy and safety of etanercept 50 mg twice a week in patients with rheumatoid arthritis who had a suboptimal response to etanercept 50 mg once a week: results of a multicenter, randomized, double-blind, active drug-controlled study.
    Weinblatt ME, Schiff MH, Ruderman EM, Bingham CO, Li J, Louie J, Furst DE.
    Arthritis Rheum; 2008 Jul 30; 58(7):1921-30. PubMed ID: 18576334
    [Abstract] [Full Text] [Related]

  • 40. A randomised controlled trial of etanercept and methotrexate to induce remission in early inflammatory arthritis: the EMPIRE trial.
    Nam JL, Villeneuve E, Hensor EM, Wakefield RJ, Conaghan PG, Green MJ, Gough A, Quinn M, Reece R, Cox SR, Buch MH, van der Heijde DM, Emery P.
    Ann Rheum Dis; 2014 Jun 30; 73(6):1027-36. PubMed ID: 24618266
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.